Literature DB >> 23403388

Peripapillary choroidal neovascular membrane in a teenage boy: presenting feature of idiopathic intracranial hypertension and resolution with intravitreal bevacizumab.

Michel J Belliveau1, Lin Xing, David R P Almeida, Jeffrey S Gale, Martin W ten Hove.   

Abstract

Peripapillary choroidal neovascular membrane (ppCNVM) is an infrequent finding in patients with idiopathic intracranial hypertension (IIH). In the pediatric subgroup there is only a single previously reported case. We describe the use of intravitreal bevacizumab for ppCNVM in a teenage boy with IIH.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23403388     DOI： 10.1097/WNO.0b013e318281b7b9

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN： 1070-8022            Impact factor:   3.042


  3 in total

1.  Management of Peripapillary Choroidal Neovascular Membrane in Patients With Idiopathic Intracranial Hypertension.

Authors:  Cem Ozgonul; Omar Moinuddin; Metasebia Munie; Michael S Lee; M Tariq Bhatti; Klara Landau; Gregory P Van Stavern; Devin D Mackay; Maud Lebas; Lindsey B DeLott; Wayne T Cornblath; Cagri G Besirli
Journal:  J Neuroophthalmol       Date:  2019-12       Impact factor: 3.042

2.  Regression of Bilateral Peripapillary Choroidal Neovascularization Associated with Idiopathic Intracranial Hypertension after Systemic Acetazolamide Treatment.

Authors:  Omer Trivizki; Liang Wang; Prashanth Iyer; Yingying Shi; Philip J Rosenfeld; David Rabinovitch; Justin Townsend
Journal:  Case Rep Ophthalmol       Date:  2022-04-19

3.  Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab.

Authors:  Nitin Kumar; Basavraj Tigari; Mohit Dogra; Ramandeep Singh
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.